"2021 Research in Review: Dr. Manish Shah (@mdmanishshah) and colleagues led a Phase III study to evaluate efficacy and safety in Andecaliximab with mFOLFOX6 as first-line treatment in patients w/advanced gastric or GEJ adenocarcinoma: https://t.co/KD0YD7DZ12 #wcmresearch"